NVAX Competitors & Alternatives
Compare Novavax Inc with similar stocks in the same industry
Biotechnology
NVAX
Main Stock$8.91
Tradestie Score
53
Market Cap
$1.54B
Revenue Growth
-0.8%
Analyst Upside
+58.4%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNKD
Mannkind Corporation
|
$4.04
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$41.27
|
$1.63B | - | 64 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.17
|
$1.57B | - | 59 | Compare |
|
VCEL
Vericel Corporation
|
$47.49
|
$1.56B | 109.8 | 61 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$98.64
|
$1.55B | - | 59 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$35.54
|
$1.55B | 15.3 | 57 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$35.07
|
$1.55B | - | 62 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.03
|
$1.50B | 7.7 | 55 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$51.64
|
$1.50B | - | 58 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$17.41
|
$1.49B | - | 58 | Compare |
More NVAX Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry